Bimekizumab safe and effective for AS and PsA in long-term trials
Crossref DOI link: https://doi.org/10.1038/s41584-022-00823-2
Published Online: 2022-08-03
Published Print: 2022-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Phillips, Robert
Text and Data Mining valid from 2022-08-03
Version of Record valid from 2022-08-03
Article History
First Online: 3 August 2022